名称 | 品牌 | 货号 | 规格 | 价格 |
---|---|---|---|---|
抗TNFRSF7 / CD27 相关抗体 (varlilumab) |
Seebio | FKX0005A-50μg | 50μg |
540.00594.00
|
抗Siglec-2 / CD22 相关抗体 (inotuzumab) |
Seebio | FKX0004A-1mg | 1mg |
2,700.002,970.00
|
抗Siglec-2 / CD22 相关抗体 (inotuzumab) |
Seebio | FKX0004A-100μg | 100μg |
900.00990.00
|
抗Siglec-2 / CD22 相关抗体 (inotuzumab) |
Seebio | FKX0004A-50μg | 50μg |
540.00594.00
|
抗CD19 相关抗体 (tafasitamab) |
Seebio | FKX0003A-1mg | 1mg |
2,700.002,970.00
|
抗CD19 相关抗体 (tafasitamab) |
Seebio | FKX0003A-100μg | 100μg |
900.00990.00
|
抗CD19 相关抗体 (tafasitamab) |
Seebio | FKX0003A-50μg | 50μg |
540.00594.00
|
抗CD19 相关抗体 (inebilizumab) |
Seebio | FKX0002A-1mg | 1mg |
2,700.002,970.00
|
抗CD19 相关抗体 (inebilizumab) |
Seebio | FKX0002A-100μg | 100μg |
900.00990.00
|
抗CD19 相关抗体 (inebilizumab) |
Seebio | FKX0002A-50μg | 50μg |
540.00594.00
|
抗AXL / UFO 相关抗体 (enapotamab) |
Seebio | FKX0001A-1mg | 1mg |
2,700.002,970.00
|
抗AXL / UFO 相关抗体 (enapotamab) |
Seebio | FKX0001A-100μg | 100μg |
900.00990.00
|
抗AXL / UFO 相关抗体 (enapotamab) |
Seebio | FKX0001A-50μg | 50μg |
540.00594.00
|
小胶质细胞/巨噬细胞特异性蛋白抗体(免疫组化) |
Seebio | EXJ6015B-50UG | 50μg |
询价
|
Complement C4c |
BioPorto | CAM 072-18-1 | 1ml |
40,512.9650,641.20
|
yENaC (y-subunit epithelial sodium channel, neoepitope) |
BioPorto | CAM 035-01-1 | 1ml |
40,512.9650,641.20
|
Factor XII (human, heavy chain) |
BioPorto | CAM 011-37-1 | 1ml |
40,512.9650,641.20
|
Factor XII (human, heavy chain) |
BioPorto | CAM 011-05-1 | 1ml |
40,512.9650,641.20
|
Complement Component C3 (human) |
BioPorto | CAM 008-01-1 | 1ml |
40,512.9650,641.20
|
Anti-yENaC (y-subunit epithelial sodium channel) |
BioPorto | CAM 005-02-1 | 1ml |
40,512.9650,641.20
|